Get informed when a big investor buys or sells
+ FollowUndervalued by 38.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $3.82 Billion |
|---|---|
| Enterprise Value | $3.72 Billion |
| Annual dividend | $0.30 |
| Dividend yield | 3.95% |
| Earnings per Share | $0.39 |
| Beta | 0.35 |
| Outstanding Shares | 502,926,852 |
| P/E Ratio | 13.94 |
|---|---|
| PEG | 5.45 |
| Price to Sales | 3.8 |
| Price to Book Ratio | 1.9 |
| Enterprise Value to Revenue | 3.69 |
| Enterprise Value to EBIT | 13.86 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the manufacturing and global distribution of a wide array of both traditional Chinese and Western pharmaceutical products. The company's diverse offerings are available in numerous form...